Hologic, Inc. (HOLX): Price and Financial Metrics

Hologic, Inc. (HOLX)

Today's Latest Price: $69.51 USD

1.28 (1.88%)

Updated Nov 27 1:00pm

Add HOLX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

HOLX Stock Summary

  • With a market capitalization of $17,535,770,671, Hologic Inc has a greater market value than 89.03% of US stocks.
  • Hologic Inc's stock had its IPO on March 26, 1990, making it an older stock than 84.84% of US equities in our set.
  • In terms of twelve month growth in earnings before interest and taxes, Hologic Inc is reporting a growth rate of -1,060.74%; that's higher than only 1.81% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Hologic Inc are GRUB, QRTEA, IVAC, REVG, and AMG.
  • Visit HOLX's SEC page to see the company's official filings. To visit the company's web site, go to www.hologic.com.

HOLX Stock Price Chart Interactive Chart >

Price chart for HOLX

HOLX Price/Volume Stats

Current price $69.51 52-week high $77.49
Prev. close $68.23 52-week low $26.49
Day low $68.39 Volume 624,400
Day high $69.53 Avg. volume 2,501,726
50-day MA $68.32 Dividend yield N/A
200-day MA $56.61 Market Cap 17.86B

Hologic, Inc. (HOLX) Company Bio

Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.

HOLX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$69.51$38.36 -44%

We started the process of determining a valid price forecast for Hologic Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Hologic Inc ranked in the 34th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 44%. As for the metrics that stood out in our discounted cash flow analysis of Hologic Inc, consider:

  • HOLX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 26.29% of tickers in our DCF set.
  • Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 8. This value is greater than just 20.97% stocks in the Healthcare sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

CMD, DYNT, MD, RSCF, and GSK can be thought of as valuation peers to HOLX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

HOLX Latest News Stream

Event/Time News Detail
Loading, please wait...

HOLX Latest Social Stream

Loading social stream, please wait...

View Full HOLX Social Stream

Latest HOLX News From Around the Web

Below are the latest news stories about Hologic Inc that investors may wish to consider to help them evaluate HOLX as an investment opportunity.

C-Arms Market Worth Observing Growth | Hologic Inc., Villa Sistemi Medicali Spa., STEPHANIX,MS WESTFALIA GMBH, Siemens Healthcare GmbH., Ziehm Imaging, Koninklijke Philips N.V., Canon Inc

C-Arms Market research report gives details of recent developments, product launches, joint ventures, mergers, acquisitions, and competitive research by the several key players and brands that are driving the market. While forming this top-class market report containing detailed market analysis, inputs

OpenPR | October 1, 2020

Hysteroscope Market revenue strategy 2020 | Stryker, Olympus Corporation, Ethicon, Hologic, etc

The market report study titled ‘Global Hysteroscope Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects,

OpenPR | October 1, 2020

Trichomonas Rapid Testing Market 2020 – Revenue Status & Forecast Report 2025 | Quidel Corporation, Sekisui Diagnostics, Nanjing Liming Bio-Products, Hologic Inc

Trichomonas Rapid Testing Market 2020 Global Industry research report studies latest Trichomonas Rapid Testing industry aspects market size, share, trends, growth, business overview and Trichomonas Rapid Testing industry scenario during the forecast period (2020-2025). Global Trichomonas Rapid Testing Market overview: Trichomonas rapid

OpenPR | September 30, 2020

Mobile C-Arm Equipment Market Sees a Faster Rebound in the Era of COVID-19 | Industry Size, Share, Growth Factors, Development Strategy, Top Leaders- GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Siemens Healthineers AG, CANON MEDICAL SYSTEMS CO

DBMR has added a new report titled Mobile C-Arm Equipment Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from

OpenPR | September 30, 2020

Anatomic Pathology Market worth USD 46.8 Billion by 2025 | Leading Companies are F. Hoffmann-La Roche Ltd, Danaher Corporation, PHP Holdings Corporation, Hologic, Agilent Technologies, Becton, Dickinson and Company, Sakura Finetek, Merck KGaA, Bio SB, Dia

According to the new market research report "Anatomic Pathology Market by Product & Service [Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)], End User, Region - Global Forecasts to 2025", published by MarketsandMarkets™, analyzes and

OpenPR | September 28, 2020

Read More 'HOLX' Stories Here

HOLX Price Returns

1-mo -0.26%
3-mo 15.14%
6-mo 31.15%
1-year 35.23%
3-year 71.84%
5-year 73.51%
YTD 33.14%
2019 27.03%
2018 -3.86%
2017 6.56%
2016 3.70%
2015 44.69%

Continue Researching HOLX

Want to see what other sources are saying about Hologic Inc's financials and stock price? Try the links below:

Hologic Inc (HOLX) Stock Price | Nasdaq
Hologic Inc (HOLX) Stock Quote, History and News - Yahoo Finance
Hologic Inc (HOLX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7971 seconds.